Literature DB >> 29466262

Post-Hospital Medication Discrepancies at Home: Risk Factor for 90-Day Return to Emergency Department.

Linda L Costa1, Ha Do Byon.   

Abstract

The purpose of this study was to evaluate the occurrence of medication discrepancies during transitional care home visits and the association with emergency department (ED) visits. Using secondary data analysis, the relationships between in-home medication discrepancies and 30- and 90-day ED utilization were examined. For every in-home medication discrepancy, the odds of being admitted to the ED within 90 days increased by 31%. This brief intervention could add a valuable component to post-hospital transition management.

Mesh:

Year:  2018        PMID: 29466262     DOI: 10.1097/NCQ.0000000000000278

Source DB:  PubMed          Journal:  J Nurs Care Qual        ISSN: 1057-3631            Impact factor:   1.597


  4 in total

1.  Risk factors for clinically relevant deviations in patients' medication lists reported by patients in personal health records: a prospective cohort study in a hospital setting.

Authors:  Denise J van der Nat; Margot Taks; Victor J B Huiskes; Bart J F van den Bemt; Hein A W van Onzenoort
Journal:  Int J Clin Pharm       Date:  2022-01-15

2.  The value of incorporating patient-consulted medication reconciliation in influencing drug-related actions in the outpatient rheumatology setting.

Authors:  Denise J van der Nat; Victor J B Huiskes; Aatke van der Maas; Judith Y M N Derijks-Engwegen; Hein A W van Onzenoort; Bart J F van den Bemt
Journal:  BMC Health Serv Res       Date:  2022-08-05       Impact factor: 2.908

3.  Emergency department visits of older adults within 30 days of discharge: analysis from the pharmacotherapy perspective.

Authors:  Fabiana Silvestre Dos Santos; Bianca Menezes Dias; Adriano Max Moreira Reis
Journal:  Einstein (Sao Paulo)       Date:  2019-10-24

4.  Monitoring adverse drug reactions in the community settings.

Authors:  Ab Fatah Ab Rahman
Journal:  Bull World Health Organ       Date:  2019-11-01       Impact factor: 9.408

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.